HearX Group Seeks To Provide Clinical Hearing Test Solutions
HearX Group Seeks To Provide Clinical Hearing Test Solutions. The HearX Group offers the world’s first clinical smartphone hearing test solutions. Its award-winning products are used in over 25 countries. The company aims to impact an individual, community and global level by creating sustainable, smart solutions for hearing health for everyone.
The current COVID-19 pandemic and social distancing has severely affected hearing healthcare clinics and centres globally and has made it increasingly difficult for professionals to provide their patients with treatment and support. This is where HearX has clinics and centres covered, with remote mobile audiology solutions for safe at-distance hearing testing. The HearX Self Test Kit and HearDigits solutions aim to equip hearing healthcare professionals, to deliver touch less audiometry and ensure a continuous income stream.
The HearX Self Test Kit is a tablet-based hearing test solution for diagnostic assessments outside a sound booth and allows for self-testing counter-side, curb-side or at home with telehealth support. This solution even allows treatment recommendations, including the fitting of hearing aids that can be provided in low or no-touch alternative models of care.
In addition to the HearX Self Test Kit, HearDigits offers a lead generation solution complementing the remote hearing offering. HearDigits is a customisable hearing screening widget embedded on a professional’s website. Using breakthrough, clinically valid speech-in-noise technology, the 2 minute test generates qualified referrals for hearing aid purchases from the clinic/centre’s website.
Bose Ventures, who invests in, and collaborates with, start-ups focused on technologies to help people live and feel better; recognized the value that HearX’s suite of smart hearing technologies bring to the world by investing in HearX, at the end of 2019.
More than 466 million people worldwide suffer from disabling hearing loss and access to hearing care is severely limited, especially in developing countries. Hearing test equipment is prohibitively expensive and hearing aids unaffordable to most. This latest round of funding helps support its suite of technologies to lead the way towards its vision of healthy hearing for everyone, everywhere.
